The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease
Open accessAbstract
Diabetes mellitus (DM) is increasingly recognized as a heterogeneous condition. The individualization of care and treatment necessitates an understanding of the individual patient's pathophysiology of DM that underpins their DM classification and clinical presentation. Classical type-2 diabetes mellitus is due to a combination of insulin resistance and an insulin secretory defect. Type-1 diabetes is characterized by a near-absolute deficiency of insulin secretion. More recently, advances in genetics and a better appreciation of the atypical features of DM has resulted in more categories of diabetes. In the context of kidney disease, patients with DM and microalbuminuria are more insulin resistant, and insulin resistance may be a pathway that results in accelerated progression of diabetic kidney disease. This review summarizes the updated classification of DM, including more rarer categories and their associated renal manifestations that need to be considered in patients who present with atypical features. The benefits and limitations of the tests utilized to make a diagnosis of DM are discussed. We also review the putative pathways and mechanisms by which insulin resistance drives the progression of diabetic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Maassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s103 · Cited by 439
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294
Accuracy and predictive value of classification schemes for ketosis-prone diabetes
Balasubramanyam, A., Garza, G., Rodriguez, L., Hampe, C. S., Gaur, L., Lernmark, A., & Maldonado, M. R. (2006) · Diabetes Care · doi:10.2337/dc06-0749 · Cited by 166
Loss of Podocyte aPKCλ/ι Causes Polarity Defects and Nephrotic Syndrome
Huber, T. B., Hartleben, B. D., Winkelmann, K., Schneider, L., Becker, J. U., Leitges, M., Walz, G., Haller, H., & Schiffer, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080871 · Cited by 100
Research works printed but not linked: 61
- Halban, 2014, Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment, J Clin Endocrinol Metab, 99, 1983, 10.1210/jc.2014-1425 · DOI · Paper page
- Atkinson, 2001, Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet, 358, 221, 10.1016/S0140-6736(01)05415-0 · DOI · Paper page
- Imkampe, 2011, Trends in type 1 diabetes incidence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991–2008, Diabet Med, 28, 811, 10.1111/j.1464-5491.2011.03288.x · DOI
- Solis-Herrera, 2014, Nephropathy in youth and young adults with type 2 diabetes, Curr Diab Rep, 14, 456, 10.1007/s11892-013-0456-y · DOI
- Dart, 2012, High burden of kidney disease in youth-onset type 2 diabetes, Diabetes Care, 35, 1265, 10.2337/dc11-2312 · DOI · Paper page
- Umpierrez, 2006, Ketosis-prone type 2 diabetes: time to revise the classification of diabetes, Diabetes Care, 29, 2755, 10.2337/dc06-1870 · DOI
- Thanabalasingham, 2011, Diagnosis and management of maturity onset diabetes of the young (MODY), BMJ, 343, d6044, 10.1136/bmj.d6044 · DOI · Paper page
- Steele, 2014, Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia, JAMA, 311, 279, 10.1001/jama.2013.283980 · DOI · Paper page
- Heidet, 2010, Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases, Clin J Am Soc Nephrol, 5, 1079, 10.2215/CJN.06810909 · DOI · Paper page
- Faguer, 2011, Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood, Kidney Int, 80, 768, 10.1038/ki.2011.225 · DOI · Paper page
- Jeha, 2005, Neonatal diabetes mellitus: patient reports and review of current knowledge and clinical practice, J Pediatr Endocrinol Metab, 18, 1095, 10.1515/JPEM.2005.18.11.1095 · doi:10.1515/jpem.2005.18.11.1095
- Naing, 2014, Maternally inherited diabetes and deafness (MIDD): diagnosis and management, J Diabetes Complications, 28, 542, 10.1016/j.jdiacomp.2014.03.006 · DOI
- Tuomi, 2014, The many faces of diabetes: a disease with increasing heterogeneity, Lancet, 383, 1084, 10.1016/S0140-6736(13)62219-9 · DOI · Paper page
- Adler, 2008, Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults, Diabetes Care, 31, 1789, 10.2337/dc08-0466 · DOI
- Adler, 2011, Hyperglycemia and death in cystic fibrosis-related diabetes, Diabetes Care, 34, 1577, 10.2337/dc10-2289 · DOI
- Creighton Mitchell, 2014, Diabetes and hemochromatosis, Curr Diab Rep, 14, 488, 10.1007/s11892-014-0488-y · DOI
- Farmer, 2012, Use of HbA1c in the diagnosis of diabetes, BMJ, 345, e7293, 10.1136/bmj.e7293 · DOI
- 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
- Genuth, 2006, Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes, Endocr Pract, 12, 34, 10.4158/EP.12.S1.34 · DOI
- 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Yip, 1993, Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria, Lancet, 341, 369, 10.1016/0140-6736(93)90167-F · DOI
- Yip, 1993, Insulin resistance in insulin-dependent diabetic patients with microalbuminuria, Lancet, 342, 883, 10.1016/0140-6736(93)91943-G · DOI · Paper page
- Parvanova, 2006, Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion, Diabetes, 55, 1456, 10.2337/db05-1484 · DOI · Paper page
- Dwyer, 2012, Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND Study, Cardiorenal Med, 2, 1, 10.1159/000333249 · DOI
- MacIsaac, 2004, Nonalbuminuric renal insufficiency in type 2 diabetes, Diabetes Care, 27, 195, 10.2337/diacare.27.1.195 · DOI · Paper page
- Caramori, 2003, Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions, Diabetes, 52, 1036, 10.2337/diabetes.52.4.1036 · DOI · Paper page
- Lorenzo, 2008, Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria, Clin J Am Soc Nephrol, 3, 783, 10.2215/CJN.02730707 · DOI
- Sasson, 2012, Renal hyperfiltration related to diabetes mellitus and obesity in human disease, World J Diabetes, 3, 1, 10.4239/wjd.v3.i1.1 · DOI · Paper page
- Mogensen, 1986, Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy, Scand J Clin Lab Invest, 46, 201, 10.3109/00365518609083660 · DOI · Paper page
- Mogensen, 1971, Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus, Scand J Clin Lab Invest, 28, 91, 10.3109/00365517109090667 · doi:10.3109/00365517109090667
- Lurbe, 2002, Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes, N Engl J Med, 347, 797, 10.1056/NEJMoa013410 · DOI · Paper page
- Poulsen, 1994, Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients, Diabetes, 43, 1248, 10.2337/diab.43.10.1248 · DOI · Paper page
- Gnudi, 2007, Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism, J Am Soc Nephrol, 18, 2226, 10.1681/ASN.2006121362 · DOI
- De Vriese, 2001, Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide, Kidney Int, 60, 202, 10.1046/j.1523-1755.2001.00787.x · DOI
- Kagami, 1994, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells, J Clin Invest, 93, 2431, 10.1172/JCI117251 · DOI · Paper page
- Sharma, 2005, TGF-beta impairs renal autoregulation via generation of ROS, Am J Physiol Renal Physiol, 288, F1069, 10.1152/ajprenal.00345.2004 · DOI
- Anderson, 1995, Current concepts of renal hemodynamics in diabetes, J Diabetes Complications, 9, 304, 10.1016/1056-8727(95)80028-D · DOI
- Raij, 2005, The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease, Am J Hypertens, 18, 95S, 10.1016/j.amjhyper.2004.11.040 · DOI
- Maddox, 2000, Glomerular ultrafiltration, 319
- Arima, 2003, The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy, Nephrol Dial Transplant, 18, 1966, 10.1093/ndt/gfg263 · DOI
- Trevisan, 1998, Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria, Diabetes, 47, 1347
- Vedovato, 2004, Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance, Diabetologia, 47, 300, 10.1007/s00125-003-1303-5 · DOI
- Wilding, 2014, The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors, Metabolism, 63, 1228, 10.1016/j.metabol.2014.06.018 · DOI · Paper page
- Rahmoune, 2005, Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes, Diabetes, 54, 3427, 10.2337/diabetes.54.12.3427 · DOI · Paper page
- Cherney, 2014, Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus, Circulation, 129, 587, 10.1161/CIRCULATIONAHA.113.005081 · DOI · Paper page
- Shimabukuro, 2003, Hypoadiponectinemia is closely linked to endothelial dysfunction in man, J Clin Endocrinol Metab, 88, 3236, 10.1210/jc.2002-021883 · DOI · Paper page
- Deng, 2010, Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway, Int J Obes (Lond), 34, 165, 10.1038/ijo.2009.205 · DOI · Paper page
- Sharma, 2009, The link between obesity and albuminuria: adiponectin and podocyte dysfunction, Kidney Int, 76, 145, 10.1038/ki.2009.137 · DOI · Paper page
- Thorn, 2005, Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study), Diabetes Care, 28, 2019, 10.2337/diacare.28.8.2019 · DOI · Paper page
- Christou, 2014, The role of adiponectin in renal physiology and development of albuminuria, J Endocrinol, 221, R49, 10.1530/JOE-13-0578 · DOI
- Fischer, 2002, Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass, Acta Diabetol, 39, 105, 10.1007/s005920200027 · DOI · Paper page
- Hunley, 2010, Scope and mechanisms of obesity-related renal disease, Curr Opin Nephrol Hypertens, 19, 227, 10.1097/MNH.0b013e3283374c09 · DOI
- Wolf, 1999, Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments], Kidney Int, 56, 860, 10.1046/j.1523-1755.1999.00626.x · DOI · Paper page
- Otero, 2005, Leptin, from fat to inflammation: old questions and new insights, FEBS Lett, 579, 295, 10.1016/j.febslet.2004.11.024 · DOI · Paper page
- Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system?, Diabetologia, 41, 1241, 10.1007/s001250051058 · DOI · Paper page
- Wisse, 2004, The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity, J Am Soc Nephrol, 15, 2792, 10.1097/01.ASN.0000141966.69934.21 · DOI · Paper page
- Gnudi, 2012, Cellular and molecular mechanisms of diabetic glomerulopathy, Nephrol Dial Transplant, 27, 2642, 10.1093/ndt/gfs121 · DOI
- Welsh, 2010, Insulin signaling to the glomerular podocyte is critical for normal kidney function, Cell Metab, 12, 329, 10.1016/j.cmet.2010.08.015 · DOI · Paper page
- Coward, 2005, The human glomerular podocyte is a novel target for insulin action, Diabetes, 54, 3095, 10.2337/diabetes.54.11.3095 · DOI · Paper page
- Coward, 2007, Nephrin is critical for the action of insulin on human glomerular podocytes, Diabetes, 56, 1127, 10.2337/db06-0693 · DOI
- Fornoni, 2010, Proteinuria, the podocyte, and insulin resistance, N Engl J Med, 363, 2068, 10.1056/NEJMcibr1008395 · doi:10.1056/nejmcibr1008395
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
“ciency, treatment requirements and prognosis varies between patients.(38,39) Although treatments are available, diabetes remains a leading cause of blindness, end-stage renal disease, lower limb amputation and cardiovascular disease.”
Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
Gnudi, L., Coward, R. J. M., & Long, D. A. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.07.002 · Cited by 332
Self-citationSensing Technologies for Detection of Acetone in Human Breath for Diabetes Diagnosis and Monitoring
Saasa, V., Malwela, T., Beukes, M., Mokgotho, M., Liu, C.-P., & Mwakikunga, B. (2018) · Diagnostics · doi:10.3390/diagnostics8010012 · Cited by 287
Metadata
- Authors
- Karalliedde, J., & Gnudi, L.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-30
- Volume
- 31
- Issue
- 2
- Pages
- 206-213
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2140437852
- Cited by
- 183
- References
- 9
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/gfu405
- The paper
- Karalliedde, J., & Gnudi, L. (2016). Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfu405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.